From steel engineering to ovarian tumor research
Ashutosh Kumar, a materials science and engineering PhD student and MathWorks Fellow, applies his eclectic skills to studying the relationship between bacteria and cancer.
Ashutosh Kumar, a materials science and engineering PhD student and MathWorks Fellow, applies his eclectic skills to studying the relationship between bacteria and cancer.
New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.
Immunai’s founders were researchers at MIT when they launched their company to help predict how patients will respond to new treatments.
In MIT’s 2024 Killian Lecture, chemical engineer Paula Hammond described her groundbreaking work on nanoparticles designed to attack tumor cells.
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
The technology could offer a cheap, fast way to test for PFAS, which have been linked to cancer and other health problems.
Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.
A new microscopy technique that enables high-resolution imaging could one day help doctors diagnose and treat brain tumors.
The MIT professor emerita and pioneering molecular biologist is being honored for her advocacy for women in science.
A compound originally developed to treat cancer could be repurposed to treat polycystic kidney disease, an inherited condition that can lead to kidney failure.